๐๏ธ Verified NIH Record โข Updated 2026-03-04
SenseToKnow Autism Screening Device Validation Study (NCT05874466)
SenseToKnow STAR Study: A Study of Technologies for Assessing Children's Development
๐ข Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: Duke University
๐ฉบ Plain-English Summary (8th-Grade Level)
This is a pivotal, prospective, double-blind, study to evaluate the sensitivity and specificity of the SenseToKnow device for the detection of autism spectrum disorder in children 16-36 months of age.
Who can join: Review the eligibility criteria below.
Location: Duke University โ Durham, North Carolina
Age range: 16 Months to 36 Months
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Duke University โ Durham, North Carolina
๐ Contact the Study Coordinator
Phone: (919) 668-0070
Email: geraldine.dawson@duke.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Autism
- The Effectiveness of an Autistic-delivered Peer-support Intervention for Autistic Adults: Community Autism Peer Specialist (CAPS) Program โ Philadelphia, Pennsylvania
- Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism โ La Jolla, California
- Developing Treatment, Treatment Validation and Treatment Scope in the Setting of an Autism Clinical Trial โ Piscataway, New Jersey
- Culturally Adapted RUBI for Spanish-Speaking Families in Texas and Mexico โ Waco, Texas
- An Open Label Study of CM-AT for the Treatment of Children With Autism โ Phoenix, Arizona
- Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism โ Piscataway, New Jersey
Explore by condition: All Autism clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.